ChemoCentryx
CCXI
#3217
Rank
A$5.75 B
Marketcap
$80.06
Share price
0.00%
Change (1 day)
35.06%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -A$0.19 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are A$37.2 Million. In 2021 the company made an earning of -A$0.2 Billion a decrease over its 2020 earnings that were of -A$81.18 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$0.19 Billion-8.94%
2021 -A$0.2 Billion144.84%
2020 -A$81.18 Million-1.18%
2019 -A$82.14 Million45.17%
2018 -A$56.58 Million-305.69%
2017 A$27.5 M-144.7%
2016 -A$61.54 Million-15.52%
2015 -A$72.85 Million0.85%
2014 -A$72.23 Million21.47%
2013 -A$59.47 Million-1.24%
2012 -A$60.21 Million906.88%
2011 -A$5.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$2.02 B-1,106.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.88 B-5,510.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.42 B-3,293.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$10.6 Billion 5,167.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.32 B-14,184.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.20 B-3,682.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.87 Billion 828.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.27 B-733.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$25.39 B-12,726.34%๐Ÿ‡บ๐Ÿ‡ธ USA